BEONE

Serial Number 98850900
661

Registration Progress

Application Filed
Nov 13, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

BEONE

Basic Information

Serial Number
98850900
Filing Date
November 13, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
661
Status Date
Oct 8, 2025
Application
Pending
Classes
005 040 042 044

Rights Holder

BEONE MEDICINES I GMBH

16
Address
AESCHENGRABEN 27
BASEL 4051
CH

Ownership History

BeiGene Switzerland GMBH

Original Applicant
16
Basel CH

BEONE MEDICINES I GMBH

New Owner Before Publication #1
16
BASEL CH

Legal Representation

Attorney
Kristen S. Ruisi

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

14 events
Date Code Type Description Documents
Oct 8, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 30, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 30, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 10, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jul 9, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jun 27, 2025 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Jun 27, 2025 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Mar 30, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 30, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 30, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 30, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 30, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 30, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 13, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs in the nature of pharmaceutical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; crude drugs in the nature of pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Biochemical preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
Class 040
Custom manufacturing services in the nature of chemical processing and production of medicines and pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
Class 042
Research and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; scientific research in the nature of conducting clinical trials for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological research; quality control for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing; cloud computing featuring software for use in database management, word processing, spreadsheet management, tracking; packaging design
Class 044
Telemedicine services; health care; convalescent home services; physical therapy services; health counseling; pharmacy advice, namely, pharmaceutical advice

Additional Information

Design Mark
The mark consists of the word BEONE in stylized form to the right of a shaded square with a stylized square and a star in the center of the stylized square.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
BE ONE; BE 1

Classification

International Classes
005 040 042 044